Nathan Bucay
Impact in
-
- Bone health and osteoporosis research
- Cancer Research top 2%
- MicroRNA in disease regulation
Papers in
-
- MicroRNA in disease regulation 10
- Cancer-related molecular mechanisms research 7
-
- CRISPR and Genetic Engineering 6
- Circular RNAs in diseases 5
- Pluripotent Stem Cells Research 4
- RNA modifications and cancer 4
- Extracellular vesicles in disease 2
- Co-authors
- W. Scott SimonetJ E TarpleyWeili XuC. CapparelliDavid L. LaceyColin R. DunstanSean MoronyHong‐Lin Tan
- Journals
- Journal of Visualized Experiments (4 papers)Cancer Research (4 papers)Stem Cells (3 papers)Journal of Biological Chemistry (3 papers)Oncotarget (2 papers)
- Partner nations
- United StatesJapanGermany
In The Last Decade
Nathan Bucay
30 papers receiving 4.9k citations
Hit Papers
Peers
Comparison fields: 5 of 109
- Orthopedics and Sports Medicine 588
- Cancer Research 912
- Oncology 1.6k
- Molecular Biology 3.7k
- Nephrology 359
Countries citing papers authored by Nathan Bucay
This map shows the geographic impact of Nathan Bucay's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Nathan Bucay with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Nathan Bucay more than expected).
Fields of papers citing papers by Nathan Bucay
This network shows the impact of papers produced by Nathan Bucay. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Nathan Bucay. The network helps show where Nathan Bucay may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Nathan Bucay, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2018 | 219 | |
| 2 | 2017 | 29 | |
| 3 | 2017 | 1 | |
| 4 | 2016 | 9 | |
| 5 | 2016 | 35 | |
| 6 | 2015 | 14 | |
| 7 | 2015 | 1 | |
| 8 | 2011 | 461 | |
| 9 | 2005 | 393 | |
| 10 | 2004 | 246 | |
| 11 | 2003 | 64 | |
| 12 | 2000 | 11 | |
| 13 | 2000 | 23 | |
| 14 | osteoprotegerin-deficient mice develop early onset osteoporosis and arterial calcification Hit paper breakdown → | 1998 | 1975 |
| 15 | Molecular characterization of ALK, a receptor tyrosine kinase expressed specifically in the nervous system Hit paper breakdown → | 1997 | 547 |
| 16 | 1996 | 190 | |
| 17 | Expression of keratinocyte growth factor in embryonic liver of transgenic mice causes changes in epithelial growth and differentiation resulting in polycystic kidneys and other organ malformations. | 1996 | 62 |
| 18 | 1995 | 146 | |
| 19 | 1991 | 110 | |
| 20 | 1988 | 36 |
About Nathan Bucay
Nathan Bucay is a scholar working on Cancer Research, Molecular Biology, Genetics, Biotechnology and Virology, having authored 30 papers that have together received 5.0k indexed citations. Recurring topics across this work include MicroRNA in disease regulation (10 papers), Cancer-related molecular mechanisms research (7 papers), CRISPR and Genetic Engineering (6 papers), Circular RNAs in diseases (5 papers), Pluripotent Stem Cells Research (4 papers), RNA modifications and cancer (4 papers), Animal Genetics and Reproduction (4 papers) and Extracellular vesicles in disease (2 papers). The work is most often cited by research in Orthopedics and Sports Medicine (588 citations), Cancer Research (912 citations), Oncology (1.6k citations), Molecular Biology (3.7k citations) and Nephrology (359 citations). Nathan Bucay has collaborated with scholars based in United States, Japan and Germany. Frequent co-authors include W. Scott Simonet, J E Tarpley, Weili Xu, C. Capparelli, David L. Lacey, Colin R. Dunstan, Sean Morony, Hong‐Lin Tan, Ildiko Sarosi and Sheila Scully. Their work appears in journals such as Journal of Visualized Experiments, Cancer Research, Stem Cells, Journal of Biological Chemistry and Oncotarget.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.